{
    "Trade/Device Name(s)": [
        "CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel: Influenza B Lineage Genotyping Kit (VER 1.1)",
        "CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel: Influenza B Lineage Genotyping Kit (VER 2)",
        "Influenza B Lineage Genotyping Kit"
    ],
    "Submitter Information": "Centers for Disease Control and Prevention",
    "510(k) Number": "K181736",
    "Predicate Device Reference 510(k) Number(s)": [
        "K172091"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OZE",
        "NSU",
        "OOI"
    ],
    "Summary Letter Date": "June 29, 2018",
    "Summary Letter Received Date": "July 2, 2018",
    "Submission Date": "June 28, 2018",
    "Regulation Number(s)": [
        "21 CFR 866.3980",
        "21 CFR 862.2570"
    ],
    "Regulation Name(s)": [
        "Respiratory viral panel multiplex nucleic acid assay",
        "Instrumentation for clinical multiplex systems"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Influenza B virus (B/Victoria lineage)",
        "Influenza B virus (B/Yamagata lineage)",
        "Human RNase P gene"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal swab (NPS)",
        "Nasal swab (NS)",
        "Throat swab (TS)",
        "Nasal aspirate (NA)",
        "Nasal wash (NW)",
        "Dual nasopharyngeal/throat swab (NPS/TS)",
        "Viral culture"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Applied Biosystems (ABI) 7500 Fast Dx Real-Time PCR instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time RT-PCR",
        "Fluorescent hydrolysis probe"
    ],
    "Methodologies": [
        "RT-PCR",
        "Genotyping",
        "Nucleic acid amplification"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Reagent",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel: Influenza B Lineage Genotyping Kit for lineage identification of Influenza B viruses using RT-PCR.",
    "Indications for Use Summary": "Intended for genotyping human influenza B viruses (B/Victoria or B/Yamagata lineage) from viral RNA in upper respiratory tract specimens or viral culture to aid in epidemiological surveillance; results should be used with clinical and epidemiological information.",
    "fda_folder": "Microbiology"
}